BUPRENORPHINE - ANVISA Registration 80258020079
Access comprehensive regulatory information for BUPRENORPHINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80258020079 and manufactured by GUANGZHOU WONDFO BIOTECH CO., LTD.. The registration is held by CEPALAB LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80258020079
25351638812201819
02248312000144
Company Information
Dates and Status
Dec 03, 2018
VIGENTE
09/18/2025 19:00:01
OPIOID
FAST TEST OPI
GUANGZHOU WONDFO BIOTECH CO., LTD.
80258020082
Dec 31, 2018
MORPHINE
FAST TEST MOP
GUANGZHOU WONDFO BIOTECH CO., LTD.
80258020050
Feb 14, 2018
OPIOID
FAST TEST OXY
GUANGZHOU WONDFO BIOTECH CO., LTD.
80258020087
Jan 14, 2019
METHADONE
FAST TEST MTD
GUANGZHOU WONDFO BIOTECH CO., LTD.
80258020085
Jan 14, 2019
PROPOXYPHENE
FAST TEST PPX
GUANGZHOU WONDFO BIOTECH CO., LTD.
80258020089
Jan 14, 2019